Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis
E. Barriere et al., Role of small-conductance Ca2+-dependent K+ channels in in vitro nitric oxide-mediated aortic hyporeactivity to alpha-adrenergic vasoconstriction in rats with cirrhosis, J HEPATOL, 35(3), 2001, pp. 350-357
Background/Aims: In vitro studies have shown, that cirrhotic aortas are hyp
oreactive to the contractile effect of vasoconstrictors because upregulated
endothelial nitric oxide-synthase (NOS) overproduces nitric oxide (NO). Al
though stimulation of endothelial small-conductance Ca2+-dependent K+ (SKCa
) channels may elicit vasorelaxation in normal arteries, the role of these
channels in cirrhosis-induced hyporeactivity is unknown. Thus, the aim of t
he present study was to investigate the role of endothelial SKCa channels i
n cirrhosis-induced, NO-mediated, in vitro aortic hyporeactivity to alpha (
1)-adrenergic vasoconstrictors.
Methods: Isolated thoracic aortas from cirrhotic and normal rats were used.
The effects of apamin, a selective SKCa channel blocker, were measured on
the vascular reactivity to phenylephrine. In addition, SKCa channel protein
expression was studied. The effects of iberiotoxin and charybdotoxin, bloc
kers of other K-Ca channels, were also studied in cirrhotic aortas.
Results: Apamin suppressed cirrhosis-induced aortic hyporeactivity to pheny
lephrine in an endothelium-dependent, NOS-inhibitor-sensitive manner. SKCa
channel protein was overexpressed in cirrhotic aortic walls. Iberiotoxin ab
olished cirrhosis-induced aortic hyporeactivity to phenylephrine in an endo
thelium-dependent but NOS-inhibitor-resistant manner. Charybdotoxin did not
induce any significant increase in phenylephrine-elicited contraction.
Conclusions: In cirrhotic aortas, the overexpression and overactivity of en
dothelial SKCa channels contributes to in vitro NO-mediated hyporeactivity
to the contractile action of alpha (1)-adrenergic agonists. (C) 2001 Europe
an Association for the Study of the Liver. Published by Elsevier Science B.
V. All rights reserved.